Crescent Biopharma CBIO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 11.89 | 105.19 | 6219.74 | -25,885 | -25 | |
| 2025Q2 | 16.14 | 101.38 | -14115.01 | -32,856 | -35 | |
| 2025Q1 | 21.00 | 102.35 | -4.00 | -2,399 | -2 | |
| 2024Q4 | 24.90 | 101.52 | -11.00 | -7,333 | -7 | |
| 2024Q3 | 16.90 | 114.34 | -16.00 | -11,234 | -10 | |
| 2023Q3 | -14.00 | -1,623 | -2 | |||
| 2023Q2 | 102.96 | -13.00 | -2,543 | -2 | ||
| 2023Q1 | 3.55 | -17.00 | 178 | 0 | ||
| 2022Q4 | 99.85 | -19.00 | -40,274 | -40 | ||
| 2022Q3 | 95.09 | -17.00 | -5,166 | -5 | ||
| 2022Q2 | 47.44 | -25.00 | 51,530 | 52 | ||
| 2022Q1 | -28.00 | -14,701 | -15 | |||
| 2021Q4 | -33.00 | -20,313 | -20 | |||
| 2021Q3 | -34.00 | -25,229 | -25 | |||
| 2021Q2 | -28.00 | -19,914 | -20 | |||
| 2021Q1 | -28.00 | -22,438 | -22 | |||
| 2020Q4 | -33.00 | -18,841 | -19 | |||
| 2020Q3 | -29.00 | -16,100 | -16 | |||
| 2020Q2 | -32.00 | -17,361 | -17 | |||
| 2020Q1 | 125.04 | -18.00 | -5,068 | -4 |